Envista Holdings Corp (NVST) Downgraded to Neutral by Baird

Market Context

Envista Holdings Corp operates in the Healthcare sector. The stock currently trades at $23.39 with a market capitalization of $3.6B. The stock has gained 18.7% over the past 52 weeks.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Baird's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Envista Holdings Corp

Among the 10 most recent ratings: 2 Buy, 8 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 15, 2026	Baird	Neutral	N/A
Oct 14, 2026	Leerink Partners	Outperform	N/A
Oct 09, 2026	Piper Sandler	Neutral	N/A
Sep 28, 2026	BMO Capital	Market Perform	N/A
Sep 18, 2026	UBS	Neutral	N/A

Related Tools: Analyst Ratings Dashboard | View NVST Stock Page